Exploring the potential extended role of community pharmacy in the management of osteoarthritis : A multi-methods study with pharmacy staff and other healthcare professionals
© 2024 The Authors. Musculoskeletal Care published by John Wiley & Sons Ltd..
INTRODUCTION: Osteoarthritis is the commonest form of chronic joint pain, which patients often self-manage before seeking healthcare advice. Patients frequently seek advice from community pharmacies, and a recent policy has recommended integrating community pharmacies into long-term condition pathways. This study explored community pharmacy teams' (CPs) and other healthcare professionals' (HCPs) views on community pharmacies providing an extended role for osteoarthritis management, identifying potential barriers and facilitators to this.
METHODS: A multi-methods study comprising surveys of CPs and other HCPs, followed by qualitative interviews. Descriptive statistics were used in an exploratory analysis of the survey data. Qualitative data were analysed using reflexive thematic analysis and the identified barriers and facilitators were mapped to the Theoretical Domains Framework.
RESULT: CPs and other HCPs in the surveys and interviews reported that an extended role for osteoarthritis management could include: a subjective assessment, explaining the joint problem and its treatment, medication management and support for self-care. There was less consensus on diagnosing the problem as OA and completing an objective assessment. A key facilitator was training to deliver the role, whilst barriers were high workload and lack of access to General Practitioner medical records.
DISCUSSION: Acceptable elements of an extended community pharmacy role for osteoarthritis centre around the provision of information, advice on medication and supported self-management.
CONCLUSION: CPs are well placed to contribute towards evidenced-based osteoarthritis management. Feasibility testing of delivering the extended role is needed and future implementation requires training for CPs and raising public awareness of the extended role.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Musculoskeletal care - 22(2024), 1 vom: 05. März, Seite e1873 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Simkins, Joanna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Community pharmacy |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 13.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/msc.1873 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369429184 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369429184 | ||
| 003 | DE-627 | ||
| 005 | 20240313234634.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240308s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/msc.1873 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1326.xml |
| 035 | |a (DE-627)NLM369429184 | ||
| 035 | |a (NLM)38453169 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Simkins, Joanna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Exploring the potential extended role of community pharmacy in the management of osteoarthritis |b A multi-methods study with pharmacy staff and other healthcare professionals |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 13.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 The Authors. Musculoskeletal Care published by John Wiley & Sons Ltd. | ||
| 520 | |a INTRODUCTION: Osteoarthritis is the commonest form of chronic joint pain, which patients often self-manage before seeking healthcare advice. Patients frequently seek advice from community pharmacies, and a recent policy has recommended integrating community pharmacies into long-term condition pathways. This study explored community pharmacy teams' (CPs) and other healthcare professionals' (HCPs) views on community pharmacies providing an extended role for osteoarthritis management, identifying potential barriers and facilitators to this | ||
| 520 | |a METHODS: A multi-methods study comprising surveys of CPs and other HCPs, followed by qualitative interviews. Descriptive statistics were used in an exploratory analysis of the survey data. Qualitative data were analysed using reflexive thematic analysis and the identified barriers and facilitators were mapped to the Theoretical Domains Framework | ||
| 520 | |a RESULT: CPs and other HCPs in the surveys and interviews reported that an extended role for osteoarthritis management could include: a subjective assessment, explaining the joint problem and its treatment, medication management and support for self-care. There was less consensus on diagnosing the problem as OA and completing an objective assessment. A key facilitator was training to deliver the role, whilst barriers were high workload and lack of access to General Practitioner medical records | ||
| 520 | |a DISCUSSION: Acceptable elements of an extended community pharmacy role for osteoarthritis centre around the provision of information, advice on medication and supported self-management | ||
| 520 | |a CONCLUSION: CPs are well placed to contribute towards evidenced-based osteoarthritis management. Feasibility testing of delivering the extended role is needed and future implementation requires training for CPs and raising public awareness of the extended role | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a community pharmacy | |
| 650 | 4 | |a multi-methods | |
| 650 | 4 | |a osteoarthritis | |
| 650 | 4 | |a primary care | |
| 700 | 1 | |a Holden, Melanie A |e verfasserin |4 aut | |
| 700 | 1 | |a Babatunde, Opeyemi |e verfasserin |4 aut | |
| 700 | 1 | |a White, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Nicholls, Elaine |e verfasserin |4 aut | |
| 700 | 1 | |a Long, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Dziedzic, Krysia |e verfasserin |4 aut | |
| 700 | 1 | |a Chudyk, Adrian |e verfasserin |4 aut | |
| 700 | 1 | |a Todd, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Stanford, Colin |e verfasserin |4 aut | |
| 700 | 1 | |a Cottrell, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Edwards, John |e verfasserin |4 aut | |
| 700 | 1 | |a Healey, Emma L |e verfasserin |4 aut | |
| 700 | 1 | |a Cork, Tania |e verfasserin |4 aut | |
| 700 | 1 | |a Mallen, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a O'Brien, Nicola |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Musculoskeletal care |d 2003 |g 22(2024), 1 vom: 05. März, Seite e1873 |w (DE-627)NLM165994355 |x 1557-0681 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2024 |g number:1 |g day:05 |g month:03 |g pages:e1873 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/msc.1873 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2024 |e 1 |b 05 |c 03 |h e1873 | ||